Red Fluorescent Protein Version 2.0

Definition of cellular structure and function is an ongoing challenge facing the research community, with the complexity multiplying each time a scientist announces the discovery of new proteins and pathways. The need for more, and better tools is met often on purpose, but sometimes by serendipity. Although Mikhail Matz and colleagues might dispute that their isolation of a red fluorescent protein from a nonbioluminescent marine animal (Discosoma sp.) was serendipitous, their hypothesis was, at

Written bySusan Jenkins
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Although Mikhail Matz and colleagues might dispute that their isolation of a red fluorescent protein from a nonbioluminescent marine animal (Discosoma sp.) was serendipitous, their hypothesis was, at least, counterintuitive.1 The protein they found was only 26-30% identical to green fluorescent protein (GFP) at the amino acid level, yet it faithfully conserves GFP's b-can structure. Palo Alto, Calif.-based BD Biosciences-Clontech added this first generation fluorescent protein, DsRed1, to its Living Colors™ series—joining green, yellow, and cyan fluorescent variants to form a four-color palette.

Mutational tinkering by Clontech has doubled fluorescence intensity, decreased toxicity in vivo, halved expression time to 24 hours, and decreased aggregate formation while preserving the protein's overall structure.2 Like DsRed1, DsRed2 delivers a high signal-to-noise ratio and diminished autofluorescence, and its >50-nm red-shift from the nearest GFP variant both broadens the canvas and increases the accuracy of multi-fluorescence detection, whether through microscopy or FACS analysis.

Clontech offers ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies